VEGFA and Atrophy: If the endothelial cells of the choriocapillaris are exposed to complement activation products by repeated treatments with anti-VEGF drugs, the function and number of endothelial cells may decrease, causing circulatory insufficiency of the choriocapillaris and RPE atrophy.